Shao-hua T. Ren
Hohhot, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Oral Microcapsules Encapsulating Endometrial Regenerative Cell-Derived Exosomes Promote Intestinal Epithelial Barrier Repair and Ameliorate Experimental Colitis.
Journal: International journal of nanomedicine
Published: May 29, 2025
Exosomes derived from a mesenchymal-like endometrial regenerative cells ameliorate renal ischemia reperfusion injury through delivery of CD73.
Journal: Stem cell research & therapy
Published: January 14, 2025
Analysis of nanomedicine applications for inflammatory bowel disease: structural and temporal dynamics, research hotspots, and emerging trends.
Journal: Frontiers in pharmacology
Published: November 05, 2024
Insulin growth factor 2 contributes to adipose stem cell-derived exosome mediated angiogenesis against hind-limb ischemia injury.
Journal: Cytokine
Published: October 25, 2024
Lenvatinib, sintilimab combined interventional treatment vs bevacizumab, sintilimab combined interventional treatment for intermediate-advanced unresectable hepatocellular carcinoma.
Journal: World journal of gastroenterology
Published: July 12, 2024
IGF2 contributes to the immunomodulatory effects of exosomes from endometrial regenerative cells on experimental colitis.
Journal: International immunopharmacology
Published: May 13, 2024
Recombinant human IL-37 attenuates acute cardiac allograft rejection in mice.
Journal: Cytokine
Published: February 18, 2024
Oxymatrine attenuates chronic allograft rejection by modulating immune responses and inhibiting fibrosis.
Journal: European journal of pharmacology
Published: January 06, 2024
CD73 mediated host purinergic metabolism in intestine contributes to the therapeutic efficacy of a novel mesenchymal-like endometrial regenerative cells against experimental colitis.
Journal: Frontiers in immunology
Published: January 31, 2023
Four-Pyroptosis Gene-Based Nomogram as a Novel Strategy for Predicting the Effect of Immunotherapy in Hepatocellular Carcinoma.
Journal: BioMed research international
Published: May 01, 2022
The intellectual base and research fronts of IL-37: A bibliometric review of the literature from WoSCC.
Journal: Frontiers in immunology
Published: April 29, 2022
Efficacy and safety of sequential therapy with sorafenib and regorafenib for advanced hepatocellular carcinoma: a two-center study in China.
Journal: Journal of gastrointestinal oncology
Published: March 31, 2022
Last Updated: 09/26/2026